Evaluation of the opinions of patients applying to the emergency department in the north of Syria about COVID-19 vaccine

Yıl 2022, , 199 - 207, 30.09.2022

Bahadır Karaca , Burak Çelik

https://doi.org/10.47482/acmr.1101137

Cited By: 2

Öz

Background: In north of Syria, health care is provided with humanitarian aid. Mass vaccinations, seen as a way out of the pandemic in Syria, are to be carried out with the support of WHO and under the supervision of Turkey. In this study, we assessed the knowledge and opinions of people who applied to hospital emergency departments in north of Syria Region about COVID-19 and the vaccine.

Methods: A face-to-face survey was conducted by trained interviewers among patients and their relatives who applied to the emergency department of Azez Vatan and Çobanbey Hospitals in North of Syria Region.

Results: A total of 331 subjects, 40.2% males and 59.8% females, participated in the study. The mean age was 36.06±12.69 years. While 42.9% of the participants wanted to be vaccinated, 42% said they did not want to be vaccinated, and 15.1% were undecided. When those who answered “No and I am undecided” to the question “Would you like to be vaccinated?” were asked about their hesitations about the vaccine, 129 people indicated that they did not think the vaccines were safe, and 107 people were not sure whether the vaccines provided protection. Belief was found to have no significant effect on the desire to be vaccinated.

Conclusions: It is believed that vaccine awareness in the global sense, misconceptions and concerns about vaccines are effective and should be taken into account in vaccination activities and pandemic response in Syria as well as around the world.

Anahtar Kelimeler

COVID-19, Emergency Department, Syria, Vaccine

Kaynakça

• 1. World Health Organization. WHO coronavirus disease (COVID-19) European Region Pandemic Overview. 2022. Available at https://www.who.int/europe/emergencies/situations/covid-19 Accessed August 06, 2022
• 2. Wong MC, Wong EL, Huang J, Cheung AW, Law K, Chong MK et al. Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong. Vaccine. 2021;39(7):1148-56.
• 3. Al-Qerem WA, Jarab AS. COVID-19 vaccination acceptance and its associated factors among a Middle Eastern population. Front. Public Health. 2021;9:632914.
• 4. World Health Organization. WHO coronavirus disease (COVID-19) Dashboard. 2021. Available at https://covid19.who.int/?gclid=CjwKCAjw87SHBhBiEiwAukSeUQL2TnFRARujkxFhssHRhPeRDwfLHbFuiecr5Atd1iRQda- SCtNYRoC6ssQAvD_BwE Accessed July13, 2021
• 5. Weiss M, Schwarzenberg A, Nelson R, Sutter KM, Sutherland MD. Global economic effects of COVID-19. New York: CongressionalResearch Service (2020). William S. Hein & Company.
• 6. Kadoya Y, Watanapongvanich S, Yuktadatta P, Putthinun P, Lartey ST, Khan MS. Willing or hesitant? A socioeconomic study on the potential acceptance of COVID-19 vaccine in Japan. Int J Environ Res Public Health. 2021;18(9):4864.
• 7. Evans ML, Lindauer M, Farrell ME. A pandemic within a pandemic— Intimate partner violence during Covid-19. N Engl J Med. 2020;383(24):2302-4.
• 8. Perri M, Dosani N, Hwang SW. COVID-19 and people experiencing homelessness: challenges and mitigation strategies. Cmaj. 2020;192(26):E716-9.
• 9. Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH et al. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes. Rev. 2020;21(11):e13128.
• 10. Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021;397(10278):1023-34.
• 11. International Monetary Fund. World Economic Outlook: A Long and Difficult Ascent. Washington, DC; 2022 Oct.
• 12. Lytras T, Tsiodras S. Lockdowns and the COVID-19 pandemic: What is the endgame?. Scand. J. Public Health. 2021;49(1):37-40.
• 13. Cohen S. The Fastest Vaccine in History. UCLA Health. Available at https://connect.uclahealth.org/2020/12/10/the-fastest-vaccine-inhistory/Accessed March 27, 2021
• 14. Gallagher J. Oxford Vaccine: How Did They Make It So Quickly? BBC News. Available at https://www.bbc.co.uk/news/health-55041371 Accessed March 28, 2021
• 15. Department of Health and Human Services (HHS) of USA. Operation Warp Speed Accelerated Vaccine Process. Available at https://media.defense.gov/2020/Aug/13/2002476369/-1/-1/0/200813-DZZ999%20100.JPG Accessed March 30, 2021
• 16. Ackah M, Ameyaw L, Gazali Salifu M, Afi Asubonteng DP, Osei Yeboah C, Narkotey Annor E et al. COVID-19 vaccine acceptance among health care workers in Africa: A systematic review and metaanalysis. PloS one. 2022;17(5):e0268711.
• 17. MacDonald NE. Sage Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine 2015, 33, 4161–4164.
• 18. SAGE Working Group on Vaccine Hesitancy. Report of the SAGE Working Group on Vaccine Hesitancy. Available at https://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf Accessed December 26, 2020
• 19. Doocy, S., Lyles, E., Delbiso, T.D. et al. Internal displacement and the Syrian crisis: an analysis of trends from 2011–2014. Confl Health 9, 33(2015).
• 20. Duclos, D., Ekzayez, A., Ghaddar, F. et al. Localisation and crossborder assistance to deliver humanitarian health services in North-West Syria: a qualitative inquiry for The Lancet-AUB Commission onSyria. Confl Health 13, 20 (2019).
• 21. UNICEF Regional Director for the Middle East and Africa. Syria receives its first delivery of COVID-19 vaccines through the COVAX Facility. 2021. Available at https://www.unicef.org/mena/pressreleases/ syria-receives-its-first-delivery-covid-19-vaccines-throughcovax-facility Accessed February 30, 2021
• 22. International Blue Crescent. Kuzey Suriye’de COVID-19 tehdidine yönelik çalişmalarimizi sürdürüyoruz. 2021. Available at https://www.ibc.org.tr/TR/1444/kuzey-suriye-de-covid-19-tehdidineyonelik-calismalarimizi-surduruyoruz Accessed September 24, 2021.
• 23. Frederiksen LSF, Zhang Y, Foged C, Thakur A. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies. Front Immunol. 2020 Jul 21;11:1817.
• 24. Coustasse A, Kimble C, Maxik K. COVID-19 and Vaccine Hesitancy: A Challenge the United States Must Overcome. J Ambul Care Manage. 2021 Jan/Mar;44(1):71-75.
• 25. Kricorian K, Civen R, Equils O. COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety. Hum Vaccin Immunother. 2022 Dec 31;18(1):1950504.
• 26. Ko Y, Lee J, Kim Y, Kwon D, Jung E. COVID-19 Vaccine Priority Strategy Using a Heterogenous Transmission Model Based on Maximum Likelihood Estimation in the Republic of Korea. Int J Environ Res Public Health. 2021 Jun 15;18(12):6469.
• 27. Bingham K. The UK Government’s Vaccine Taskforce: strategy for protecting the UK and the world. Lancet. 2021 Jan 2;397(10268):68-70.
• 28. T.C. Sağlık Bakanlığı. COVID-19 Aşısı Bilgilendirme Platformu: Aşı uygulanacak grup sıralaması. 2021. Available at https://covid19asi.saglik.gov.tr/TR-77707/asi-uygulanacak-grup-siralamasi.html Accessed April 20, 2021.
• 29. CDC COVID-19 Response Team. Characteristics of health care personnel with COVID-19: United States, February 12–April 9, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 477–81.
• 30. Seyhan AU, Karaca B. Evaluation of demographic and clinical characteristics of healthcare professionals with COVID-19 in Northwest Syria Region. Turkish Bulletin of Hygiene and Experimental Biology. 2021;78(1):39-46.
• 31. Naser AY, Dahmash EZ, Alsairafi ZK, Alwafi H, Alyami H, Jalal Z, Al Rajeh AM, Paudyal V, Alhartani YJ, Turkistani FM, Hassanin FF. Knowledge and Practices during the COVID-19 Outbreak in the Middle East: A Cross-Sectional Study. Int J Environ Res Public Health. 2021 Apr 28;18(9):4699.
• 32. Mohsen F, Bakkar B, Armashi H, Aldaher N. Crisis within a crisis, COVID-19 knowledge and awareness among the Syrian population: a cross-sectional study. BMJ open. 2021;11(4):e043305.
• 33. Mannan DK, Farhana KM. Knowledge, attitude and acceptance of a COVID-19 vaccine: A global cross-sectional study. Int J Acad Res. 2020;6(4).
• 34. Lazarus, J.V., Ratzan, S.C., Palayew, A. et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med 27, 225–228 (2021).
• 35. Kerr JR, Schneider CR, Recchia G, Dryhurst S, Sahlin U, Dufouil C, Arwidson P, Freeman AL, van der Linden S. Correlates of intended COVID-19 vaccine acceptance across time and countries: results from a series of cross-sectional surveys. BMJ Open. 2021 Aug 2;11(8):e048025.
• 36. Machida M, Nakamura I, Kojima T, Saito R, Nakaya T, Hanibuchi T et al. Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic. Vaccines. 2021;9(3):210.
• 37. Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults. Ann Intern Med. 2020 Dec 15;173(12):964-973
• 38. Qunaibi EA, Helmy M, Basheti I, Sultan I. A high rate of COVID-19 vaccine hesitancy in a large-scale survey on Arabs. Elife. 2021 May 27;10:e68038.
• 39. Alqudeimat Y, Alenezi D, AlHajri B, Alfouzan H, Almokhaizeem Z, Altamimi S, Almansouri W, Alzalzalah S, Ziyab AH. Acceptance of a COVID-19 Vaccine and Its Related Determinants among the General Adult Population in Kuwait. Med Princ Pract. 2021;30(3):262-271.
• 40. Al-Mohaithef M, Padhi BK. Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey. J Multidiscip Healthc. 2020 Nov 20;13:1657-1663.
• 41. Mohamad, O., Zamlout, A., AlKhoury, N. et al. Factors associated with the intention of Syrian adult population to accept COVID19 vaccination: a cross-sectional study. BMC Public Health 21, 1310 (2021).
• 42. Salibi N, Abdulrahim S, El Haddad M, Bassil S, El Khoury Z, Ghattas H, McCall SJ. COVID-19 vaccine acceptance in older Syrian refugees: Preliminary findings from an ongoing study. Prev Med Rep. 2021 Dec;24:101606.
• 43. Allagoa DO, Oriji PC, Tekenah ES, Obagah L, Njoku C, Afolabi AS et al. Predictors of acceptance of Covid-19 vaccine among patients at a tertiary hospital in South-South Nigeria. Int J Community Med Public Health. 2021 May;8(5):2165-72.